{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-078255","form_type":"8-K","ticker":null,"cik":"0001832415","company_name":"Better Therapeutics, Inc.","filed_at":"2023-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.923925+00:00","generated_at":"2026-06-17T17:05:32.585298+00:00","sec_items":["2.05","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Better Therapeutics cuts 35% of workforce to extend cash runway ahead of FDA decision for BT-001","bullets":["Workforce reduction of approx 35% of employees, effective March 24, 2023.","Company estimates ~$400k in cash-based severance and benefits expenses in Q2 2023.","CEO Frank Karbe cites need to preserve cash for potential FDA marketing authorization and commercial launch of BT-001.","Actions taken due to industry volatility and to extend cash runway for critical milestones."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-078255","json":"https://secwatch.observer/filing/0001193125-23-078255.json","markdown":"https://secwatch.observer/filing/0001193125-23-078255.md","text":"https://secwatch.observer/filing/0001193125-23-078255.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/0001193125-23-078255-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/d484269d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T17:05:32.585298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b3219555c6742bf0484b4fa554e78a43aa4e109","claim":"Better Therapeutics, Inc. announced a restructuring with charges of approximately $400 thousand (approximately 35% of its employees).","evidence_excerpt":"On March 23 2023, Better Therapeutics, Inc. (the “Company”) announced a reduction in its workforce (the “Workforce Reduction”) of approximately 35% of its employees as part of a cost reduction initiative to improve its cash runway and focus on the long-term success of the company. The Company will complete this Workforce Reduction on March 24, 2023. The Company estimates that it will incur approximately $400 thousand in cash-based expenses related to severance and benefits in the second quarter of 2023.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/0001193125-23-078255-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $400 thousand"},{"label":"Headcount","value":"approximately 35% of its employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}